Document is current
Any future updates will be listed below
-
Authors
Jaggi, Damian
Aeberhard, Shalin G.
Artemiev, Dmitri
Zinkernagel, Martin S.
Heussen, Florian M.
- License Information
-
More Information
Article History
Received: 3 September 2024
Accepted: 20 February 2025
First Online: 27 February 2025
Declarations
:
: All participants gave written informed consent to participate in the study. The study was conducted in accordance with the Swiss Human Research Act, the ICH guidelines of Good Clinical Practice, the Declaration of Helsinki and was authorized by the local ethics committee (Kantonale Ethikkomission Bern, KEK, BASEC-ID. 2021-D0038).
: D. Jaggi, Bayer (R); S.G. Aeberhard, None; D. Artemiev, None; M.S. Zinkernagel, Bayer (F, C), Novartis (C), Roche (C); F.M. Heussen, Bayer (F, R), Carl Zeiss Meditec (C), Oertli (C), Roche (C).
: The authors declare no competing interests.
